All-cause and Diseases-specific Mortality of High-risk HPV Infection
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Observation.
- Who it may be relevant to
- Registry conditions: HPV Infection. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The corresponding prevention strategies and treatment routes of HPV infection can be provided through investigating causes of death due to HPV infection and specialized diseases.
Detailed description
Anxiety and panic about HPV infection have become common phenomena in tumor screening. Transitional and useless diagnosis and treatment caused by HPV infection are also common, affecting women's physical and mental health and health economic level. If the investigators can understand the causes of death related to HPV infection and specialized diseases, the investigators can provide corresponding prevention strategies and treatment routes from the level of health policies and individual methods and mechanisms, and also alleviate the related panic caused by HPV infection.
Interventions
- Other Observation
not available-observation study
Primary outcome measures
- HR-HPV infection AND all-cause and diseases-specific mortality [Time frame: one year]
Secondary outcome measures (2)
- time-period of HR-HPV infection AND all-cause and diseases-specific mortality [Time frame: one year]
- HR-HPV type AND all-cause and diseases-specific mortality [Time frame: one year]
Eligibility criteria
Inclusion criteria
- Female participate in at least once cervical cancer screening with clear information of HPV DNA test results;
- Having clear identification (ID number or others) that can be retrieved in the cause of death database.
Exclusion criteria
Cases that do not fully meet all inclusion criteria are used as exclusion criteria.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-only
Study locations
China · 1 center
- Peking Union Medical College Hospital — Beijing
Identifiers
NCT: NCT06631495 · HPV-ADM1